4//SEC Filing
O'Byrne Jason 4
Accession 0001628280-25-052841
CIK 0001706431other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 2:47 PM ET
Size
5.0 KB
Accession
0001628280-25-052841
Insider Transaction Report
Form 4
O'Byrne Jason
EVP & Chief Financial Officer
Transactions
- Sale
Common Stock
2025-11-17$5.56/sh−6,799$37,782→ 110,701 total
Footnotes (2)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F2]Includes 2,500 shares of common stock acquired by the Reporting Person on May 30, 2025 pursuant to an employee stock purchase program.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001871145
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 2:47 PM ET
- Size
- 5.0 KB